Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: SRT-501 |
Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI
|
Cytochrome P450 1A2 (CYP1A2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0003
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP1A2-curA interaction |
[1], [2] |
Description |
The interaction, between human Cytochrome P450 1A2 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug SRT-501, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Sulfotransferase 1C2 (SULT1C2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0614
DME Info
|
Uniprot ID |
|
Interaction Name |
SULT1C2-curA interaction |
[1], [3] |
Description |
The interaction, between human Sulfotransferase 1C2 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug SRT-501, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Cometabolized drug: Curcumin |
Click to Show/Hide the Full List of HOSPPI: 4 HOSPPI
|
UDP-glucuronosyltransferase 1A1 (UGT1A1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0004
DME Info
|
Uniprot ID |
|
Interaction Name |
UGT1A1-curA interaction |
[1], [4] |
Description |
The interaction, between human UDP-glucuronosyltransferase 1A1 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug Curcumin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
UDP-glucuronosyltransferase 1A7 (UGT1A7) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0065
DME Info
|
Uniprot ID |
|
Interaction Name |
UGT1A7-curA interaction |
[1], [4] |
Description |
The interaction, between human UDP-glucuronosyltransferase 1A7 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug Curcumin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
UDP-glucuronosyltransferase 1A8 (UGT1A8) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0064
DME Info
|
Uniprot ID |
|
Interaction Name |
UGT1A8-curA interaction |
[1], [4] |
Description |
The interaction, between human UDP-glucuronosyltransferase 1A8 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug Curcumin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
UDP-glucuronosyltransferase 1A9 (UGT1A9) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0042
DME Info
|
Uniprot ID |
|
Interaction Name |
UGT1A9-curA interaction |
[1], [4] |
Description |
The interaction, between human UDP-glucuronosyltransferase 1A9 and NADPH-dependent curcumin reductase from Escherichia coli which collectively metabolize the drug Curcumin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|